Member Info for 86KB

PJ have a read of this from todays rns

As part of the agreement, Trellus Health® will receive an undisclosed upfront licensing fee, along with a fixed monthly management fee. The one-year collaboration will provide eligible patients prescribed a Johnson & Johnson therapy access to Trellus Elevate™.

Not letting any buyers in, gap up and go tomorrow.

I reckon we could see a double bag tomorrow taking it to double digits

Much less than that majors holding majority only 70mil available and even then some holding from higher levels so even less than that available.

Possible we see double digits here over the next few sessions and still would have a tiny mcap

Certainly feels like ppp move here plus with event taken place tomorrow would get more interest and perhaps deals.

Almost double volume of available FF, this heads towards 4p+ on next run.

Well theres a gap at 5.1 and one at 9.2p so either one or both will get filled. These traded as high as 78p in 2022.

Mcap still tiny 4mil, volume has exceeded the free float of 70mil. Having a ppp moment here and that went into double digits from below 1p.

Would be great but lets not go off hearsay and wait on official news, we all know they are in discussions with many interested global pharmas.

Crazy volume over 76million in first few hours when there is only around 70million shares available out if the 161mil. Goes much higher.

This is the usual drop we have been getting and goes after or just before 11. Licensing deal lands and it goes. Just seems like we are churning a little perhaps warrants or lanstead but once done it will go.

Double digits perhaps here with not many shares being available.

Not many shares around Significant shareholdings

Significant shareholders

No. of ordinary shares

% held

Icahn School of Medicine at Mount Sinai

40,384,897

25.0%

Dowgate Group Limited

11,853,038

7.3%

Marla Dubinsky

8,750,500

5.4%

Laurie Keefer

8,759,351

5.4%

Unicorn Asset Management Limited

6,250,000

3.9%

Ian Amiee, Daryl Amiee, Doolittle act Amiee SSAS

5,365,000

3.3%

Director Shareholdings

Director

Number

Ordinary Shares %

Marla Dubinsky

8,750,500

5.4%

Mike Salter

1,126,026

.7%

True lol. There aren't alot of shares too only 161million and volume at 50million. Could it see double digits?

Amazing volume already think we will clear that churn within the day at this rate lol. X 4 the placing shares should do.

Reckon it goes even silly when early US buyers come in, usually after 11.

Perhaps it sees 10-15mcap over the coming sessions.

Crazy that after such a rise the mcap is still tiny considering agreement with a multi billion company. Think it could see 5p+

Think we could get something soon, as another company got a deal with a major.